Vector Academy

Vector Academy is our knowledge base that serves as your resource for diving deeper into all things cloning, viruses, and gene delivery. We’re excited to share our expertise and what we’ve learned from decades of collective experience with you.
  • {['All Posts'|boatFixI18n|translate]}
  • {[s[0]|boatFixI18n|translate]}

{['Popular tags'|boatFixI18n|translate]}:

{[tag|boatFixI18n|translate]}
CRISPR Library Screening Made Simple | Part 1: Setting Up for Success

Keywords: CRISPR screening, gRNA library design, in vitro and in vivo models, library preparation

Explore the critical steps in designing and performing CRISPR screens and learn what to consider to set your screening project up for success.

Read More ››
Gene Delivery Seminar Series: Modeling Neurodegenerative Disease Risk Using Induced Pluripotent Stem Cells

Keywords: Gene delivery seminar series, iPSCs, neurodegenerative disease, CRISPR

Dr. Narayan's innovative work shows how patient-derived iPSC models are transforming our understanding of AD while paving the way toward targeted therapies.

Read More ››
Optimizing CRISPR: Technology and Approaches for High Efficiency Gene Editing

Keywords: CRISPR-Cas9, genome editing, CRISPR vector design, gene knockout, gene regulation

An overview of CRISPR-Cas9 tools and mechanisms, with practical tips to optimize vector design for efficient genome editing.

Read More ››
CRISPR This Way: Choosing Between Delivery Systems

Keywords: CRISPR delivery, plasmid, virus, mRNA, RNP

A comparison of delivery systems to help you choose the optimal method for your CRISPR experiments, from research applications to clinical use.

Read More ››
Driving CAR-T Therapy in the Clinic and with CRISPR

Keywords: CAR-T cell therapy, Kymriah CAR-T, immunotherpy

A deep dive into the biology behind CAR-T vectors, their clinical applications, and how CRISPR/Cas9 is being used to create the next generation of CAR therapeutics.

Read More ››
Slipping Under Titer: Why Is My Viral Titer So Low?

Keywords: Viral titer, gene toxicity

If your viral titration is low, it could be because of titration method, improper vector or experimental design, or expression of toxic genes. Here we discuss troubleshooting all of these and more.

Read More ››
GLAd to Be Treating DMD

Keywords: Muscular dystrophy, gutless adenovirus, gene therapy

Learn about exciting gene therapy approaches utilizing AAV, adenovirus and gutless adenovirus for treating Duchenne muscular dystrophy.

Read More ››
Please let us know what you would like to hear from us about the latest technologies or discoveries by leaving feedback or contacting us.
Design My Vector Request Design Support